SUNFLOWER PHARMACEUTICAL GROUP CO., LTD.

Autres langues Sunflower Pharmaceutical Group Co., Ltd.

Actions

002737

CNE100001WT7

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 30/09/2026			Varia. 5j.	Varia. 1 janv.
11,40 ^CNY	+1,97%		+1,42%	-22,82%

28/08	Sunflower Pharmaceutical Group Co., Ltd. publie ses résultats pour le semestre clos le 30 juin 2026	CI
28/07	Sunflower Pharmaceutical se retire d'un fonds d'investissement	MT

Autres langues

28/08	Sunflower Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
28/07	Sunflower Pharmaceutical Withdraws Investment in Fund
28/07	Sunflower Pharmaceutical Commits 10 Million Yuan to Set Up Subsidiary in Sichuan, China
28/07	Sunflower Pharmaceutical Offloads Beijing Pharmastar Stake for 34 Million Yuan
27/07	Guangzhou Baiyunshan Hejigong Pharmaceutical Co., Ltd. agreed to acquire 10.39% stake in Beijing Pharmstar Pharmaceutical Technology from Sunflower Pharmaceutical Group Co., Ltd. for CNY 34.3 million.
25/05	Sunflower Pharmaceutical Group Co.,Ltd Approves Cash Dividend for 2025
06/05	Sunflower Pharmaceutical Products Selected for Bulk Chinese Medicine Procurement
29/04	Sunflower Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Sunflower Pharmaceutical Group Co., Ltd. announces Annual dividend, payable on July 17, 2026
26/04	Sunflower Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
03/03	Sunflower Pharmaceutical Names Vice Chairperson
25/02	Sunflower Pharmaceutical Gets China Approval for Anti-Constipation Product
03/02	Sunflower Pharmaceutical Subsidiary Gets China Nod for Probiotic Powder
12/12	Sunflower Pharmaceutical Group Co.,Ltd(SZSE:002737) dropped from Shenzhen Stock Exchange Component A Share Index
12/12	Sunflower Pharmaceutical Group Co.,Ltd(SZSE:002737) dropped from Shenzhen Stock Exchange Component Index
04/11	Sunflower Pharmaceutical Gets Regulatory Nod for Topical Antibiotic
27/10/25	Sunflower Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
17/10/25	Sunflower Pharmaceutical Gets China Clinical Trial Approval for Bronchitis Drug for Kids
02/09/25	Sunflower Pharmaceutical Gets Registration Certificate for Fexofenadine Hydrochloride Oral Suspension
27/08/25	Sunflower Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2025
28/07/25	Sunflower Pharmaceutical Group to Invest 20 Million Yuan in Two Subsidiaries
17/07/25	Sunflower Pharmaceutical Gets Regulatory Acceptance for Review of Vitamin K1 Drops
23/05/25	Sunflower Pharmaceutical Group Co.,Ltd Approves Cash Dividend for 2024 for 2024
09/05/25	Sunflower Pharmaceutical Gets Marketing Approval for Osteoarthritis Capsules
25/04/25	Sunflower Pharmaceutical Group Co.,Ltd Proposes Final Cash Dividend for 2024